Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 248

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Translational control of immune responses: from transcripts to translatomes

Piccirillo, Ciriaco A, Bjur, Eva, Topisirovic, Ivan, Sonenberg, Nahum, Larsson, Ola·2014·Nature Immunology
DOI 10.1038/ni.2891
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ni.2891

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 117

  1. Bava, F.A. et al. CPEB1 coordinates alternative 3′-UTR formation with translational regulation. Nature 495, 121–125 (2013). · DOI · Paper page
  2. Rousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L. & Sonenberg, N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA 93, 1065–1070 (1996). · DOI · Paper page
  3. Lindstein, T., June, C.H., Ledbetter, J.A., Stella, G. & Thompson, C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339–343 (1989). · DOI · Paper page
  4. Schena, M. et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA 93, 10614–10619 (1996). · DOI · Paper page
  5. Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470 (1995). · DOI · Paper page
  6. Lockhart, D.J. et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675–1680 (1996). · DOI · Paper page
  7. Larsson, O., Tian, B. & Sonenberg, N. Toward a genome-wide landscape of translational control. Cold Spring Harb. Perspect. Biol. 5, a012302 (2013). · DOI
  8. Vogel, C. & Marcotte, E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227–232 (2012). · DOI · Paper page
  9. Spirin, A.S. The second Sir Hans Krebs lecture. Informosomes. Eur. J. Biochem. 10, 20–35 (1969). · DOI · Paper page
  10. Keene, J.D. & Tenenbaum, S.A. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9, 1161–1167 (2002).This study introduces the present conceptual model for the regulation of gene expression at the post-transcriptional level. · DOI · Paper page
  11. Candeias, M.M. et al. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat. Cell Biol. 10, 1098–1105 (2008). · DOI · Paper page
  12. Hershey, J.W., Sonenberg, N. & Mathews, M.B. Principles of translational control: an overview. Cold Spring Harb. Perspect. Biol. 4, a011528 (2012). · DOI · Paper page
  13. Shalgi, R. et al. Widespread regulation of translation by elongation pausing in heat shock. Mol. Cell 49, 439–452 (2013). · DOI · Paper page
  14. Liu, B., Han, Y. & Qian, S.B. Cotranslational response to proteotoxic stress by elongation pausing of ribosomes. Mol. Cell 49, 453–463 (2013). · DOI · Paper page
  15. Leprivier, G. et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153, 1064–1079 (2013). · DOI · Paper page
  16. Sonenberg, N. & Hinnebusch, A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731–745 (2009). · DOI · Paper page
  17. Jackson, R.J., Hellen, C.U. & Pestova, T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113–127 (2010). · DOI · Paper page
  18. Baltz, A.G. et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 46, 674–690 (2012). · DOI · Paper page
  19. Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35–43 (1994). · DOI · Paper page
  20. Brown, E.J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756–758 (1994). · DOI · Paper page
  21. Corradetti, M.N., Inoki, K., Bardeesy, N., DePinho, R.A. & Guan, K.L. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533–1538 (2004). · DOI · Paper page
  22. Shaw, R.J. et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91–99 (2004). · DOI · Paper page
  23. Hara, K. et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484–14494 (1998). · DOI · Paper page
  24. Wang, X., Campbell, L.E., Miller, C.M. & Proud, C.G. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334, 261–267 (1998). · DOI · Paper page
  25. Laplante, M. & Sabatini, D.M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012). · DOI · Paper page
  26. Kim, D.H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163–175 (2002). · DOI · Paper page
  27. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177–189 (2002). · DOI · Paper page
  28. Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122–1128 (2004). · DOI · Paper page
  29. Sarbassov, D.D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004). · DOI · Paper page
  30. Sarbassov, D.D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168 (2006). · DOI · Paper page
  31. Heitman, J., Movva, N.R. & Hall, M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905–909 (1991). · DOI · Paper page
  32. Gingras, A.C. et al. Regulation of 4E–BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13, 1422–1437 (1999). · DOI · Paper page
  33. Brunn, G.J. et al. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256–5267 (1996). · DOI · Paper page
  34. Burnett, P.E., Barrow, R.K., Cohen, N.A., Snyder, S.H. & Sabatini, D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E–BP1. Proc. Natl. Acad. Sci. USA 95, 1432–1437 (1998). · DOI · Paper page
  35. Hara, K. et al. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272, 26457–26463 (1997). · DOI · Paper page
  36. Wullschleger, S., Loewith, R. & Hall, M.N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006). · DOI · Paper page
  37. Dorrello, N.V. et al. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467–471 (2006). · DOI · Paper page
  38. Raught, B. et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J. 23, 1761–1769 (2004). · DOI · Paper page
  39. Pause, A. et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371, 762–767 (1994). · DOI · Paper page
  40. Roux, P.P. & Topisirovic, I. Regulation of mRNA translation by signaling pathways. Cold Spring Harb. Perspect. Biol. 4, a012252 (2012). · DOI · Paper page
  41. Gingras, A.C. et al. Hierarchical phosphorylation of the translation inhibitor 4E–BP1. Genes Dev. 15, 2852–2864 (2001). · DOI · Paper page
  42. Zimmer, S.G., DeBenedetti, A. & Graff, J.R. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res. 20, 3A, 1343–1351 (2000).
  43. Colina, R. et al. Translational control of the innate immune response through IRF-7. Nature 452, 323–328 (2008).This study identifies mTORC1–4E-BP–dependent translational control of IRF7, which affects the production of type 1 interferon and susceptibility to infection with vesicular stomatitis virus. · DOI · Paper page
  44. Larsson, O. et al. Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res. 34, 4375–4386 (2006). · DOI
  45. Bilanges, B. et al. Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol. Cell. Biol. 27, 5746–5764 (2007). · DOI
  46. Patursky-Polischuk, I. et al. The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner. Mol. Cell. Biol. 29, 640–649 (2009). · DOI
  47. Avni, D., Shama, S., Loreni, F. & Meyuhas, O. Vertebrate mRNAs with a 5′-terminal pyrimidine tract are candidates for translational repression in quiescent cells: characterization of the translational cis-regulatory element. Mol. Cell. Biol. 14, 3822–3833 (1994).
  48. Miloslavski, R. et al. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner. J. Mol. Cell Biol. 10.1093/jmcb/mju008 (13 March 2014). · DOI
  49. Shama, S., Avni, D., Frederickson, R.M., Sonenberg, N. & Meyuhas, O. Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells. Gene Expr. 4, 241–252 (1995).
  50. Damgaard, C.K. & Lykke-Andersen, J. Translational coregulation of 5′TOP mRNAs by TIA-1 and TIAR. Genes Dev. 25, 2057–2068 (2011). · DOI · Paper page
  51. Tcherkezian, J. et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation. Genes Dev. 28, 357–371 (2014). · DOI · Paper page
  52. Flynn, A. & Proud, C.G. Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells. J. Biol. Chem. 270, 21684–21688 (1995). · DOI
  53. Fukunaga, R. & Hunter, T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921–1933 (1997). · DOI · Paper page
  54. Waskiewicz, A.J., Flynn, A., Proud, C.G. & Cooper, J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909–1920 (1997). · DOI · Paper page
  55. Furic, L. et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc. Natl. Acad. Sci. USA 107, 14134–14139 (2010). · DOI · Paper page
  56. Fernandez, P.C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115–1129 (2003). · DOI · Paper page
  57. Topisirovic, I. et al. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. Mol. Cell. Biol. 29, 1152–1162 (2009). · DOI
  58. Cook, K.D. & Miller, J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J. Immunol. 185, 3209–3216 (2010). · DOI · Paper page
  59. Gigoux, M. et al. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation. Mol. Immunol. 59, 46–54 (2014). · DOI
  60. Lee, M.S., Kim, B., Oh, G.T. & Kim, Y.J. OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat. Immunol. 14, 346–355 (2013).This study identifies OASL1 as a key regulator of the translation of IRF7, which affects the expression of type 1 interferon. It proposes that OASL1 acts in a negative feedback loop by suppressing the translation of IRF7 mRNA. · DOI
  61. Bjur, E. et al. Distinct translational control in CD4+ T cell subsets. PLoS Genet. 9, e1003494 (2013).This study shows that analysis of translatomes is feasible in primary cells of the immune system that are of low abundance and that such analysis provides a perspective distinct from the analysis of their transcriptomes. It also identifies eIF4E-dependent translational control as key for the proliferation of Foxp3− and Foxp3+ CD4+ T cells. · DOI
  62. Tangye, S.G., Ma, C.S., Brink, R. & Deenick, E.K. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 13, 412–426 (2013). · DOI · Paper page
  63. Araki, K., Ellebedy, A.H. & Ahmed, R. TOR in the immune system. Curr. Opin. Cell Biol. 23, 707–715 (2011). · DOI
  64. Xu, H. et al. Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 13, 642–650 (2012).This study shows that phosphorylation of eIF4E is key in the translational activation of IRF8 mRNA and downstream macrophage polarization. · DOI · Paper page
  65. Herdy, B. et al. Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E. Nat. Immunol. 13, 543–550 (2012). · DOI
  66. Nikolcheva, T. et al. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J. Clin. Invest. 110, 119–126 (2002). · DOI
  67. Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1–TH17 responses. Nat. Immunol. 12, 231–238 (2011). · DOI · Paper page
  68. Huang, J.T. & Schneider, R.J. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell 65, 271–280 (1991). · DOI · Paper page
  69. Kleijn, M., Vrins, C.L., Voorma, H.O. & Thomas, A.A. Phosphorylation state of the cap-binding protein eIF4E during viral infection. Virology 217, 486–494 (1996). · DOI
  70. Connor, J.H. & Lyles, D.S. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J. Virol. 76, 10177–10187 (2002). · DOI
  71. Walsh, D. et al. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells. Mol. Cell. Biol. 28, 2648–2658 (2008). · DOI
  72. Walsh, D., Perez, C., Notary, J. & Mohr, I. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J. Virol. 79, 8057–8064 (2005). · DOI
  73. Walsh, D. & Mohr, I. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18, 660–672 (2004). · DOI · Paper page
  74. Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715–723 (2011). · DOI · Paper page
  75. Vashchenko, G. & MacGillivray, R.T. Multi-copper oxidases and human iron metabolism. Nutrients 5, 2289–2313 (2013). · DOI · Paper page
  76. Klebanoff, S.J. Bactericidal effect of Fe2+, ceruloplasmin, and phosphate. Arch. Biochem. Biophys. 295, 302–308 (1992). · DOI
  77. Mazumder, B. & Fox, P.L. Delayed translational silencing of ceruloplasmin transcript in γ interferon-activated U937 monocytic cells: role of the 3′ untranslated region. Mol. Cell. Biol. 19, 6898–6905 (1999). · DOI
  78. Vyas, K. et al. Genome-wide polysome profiling reveals an inflammation-responsive posttranscriptional operon in gamma interferon-activated monocytes. Mol. Cell. Biol. 29, 458–470 (2009). · DOI
  79. Mukhopadhyay, R. et al. DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol. Cell 32, 371–382 (2008).These authors identify a negative feedback loop for GAIT complex activity. DAPK and ZIPK, which are activators of the GAIT complex, are themselves targets for suppressed translation via a GAIT-dependent mechanism. · DOI
  80. Scheu, S. et al. Activation of the integrated stress response during T helper cell differentiation. Nat. Immunol. 7, 644–651 (2006). · DOI · Paper page
  81. Wek, R.C., Jiang, H.Y. & Anthony, T.G. Coping with stress: eIF2 kinases and translational control. Biochem. Soc. Trans. 34, 7–11 (2006). · DOI · Paper page
  82. Villarino, A.V. et al. Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 34, 50–60 (2011).This study shows that translational control of cytokines is important for self reactive T-cell anergy. · DOI
  83. Piecyk, M. et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-α. EMBO J. 19, 4154–4163 (2000). · DOI · Paper page
  84. Katsanou, V. et al. HuR as a negative posttranscriptional modulator in inflammation. Mol. Cell 19, 777–789 (2005). · DOI · Paper page
  85. Yu, C. et al. An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response. Mol. Cell 25, 765–778 (2007). · DOI
  86. Dixon, D.A. et al. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J. Exp. Med. 198, 475–481 (2003). · DOI · Paper page
  87. Dhamija, S. et al. Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1. J. Biol. Chem. 288, 19250–19259 (2013). · DOI
  88. Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218–222 (2004). · DOI · Paper page
  89. Chang, C.H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013). · DOI · Paper page
  90. Warner, J.R., Knopf, P.M. & Rich, A. A multiple ribosomal structure in protein synthesis. Proc. Natl. Acad. Sci. USA 49, 122–129 (1963). · DOI · Paper page
  91. Johannes, G., Carter, M.S., Eisen, M.B., Brown, P.O. & Sarnow, P. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl. Acad. Sci. USA 96, 13118–13123 (1999). · DOI · Paper page
  92. Karginov, F.V. & Hannon, G.J. Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 27, 1624–1632 (2013). · DOI · Paper page
  93. Ingolia, N.T., Brar, G.A., Rouskin, S., McGeachy, A.M. & Weissman, J.S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 7, 1534–1550 (2012). · DOI · Paper page
  94. Zoschke, R., Watkins, K.P. & Barkan, A. A rapid ribosome profiling method elucidates chloroplast ribosome behavior in vivo. Plant Cell 25, 2265–2275 (2013). · DOI
  95. Larsson, O., Sonenberg, N. & Nadon, R. Identification of differential translation in genome wide studies. Proc. Natl. Acad. Sci. USA 107, 21487–21492 (2010). · DOI
  96. Olshen, A.B. et al. Assessing gene-level translational control from ribosome profiling. Bioinformatics 29, 2995–3002 (2013). · DOI
  97. Larsson, O & Nadon, R. Re-analysis of genome wide data on mammalian microRNA-mediated suppression of gene expression. Translation 1, 1–9 (2013). · DOI
  98. Eliseeva, I.A., Vorontsov, I.E., Babeyev, K.E., Buyanova, S.M., Sysoeva, M.A. & Kondrashov, F.A. et al. In silico motif analysis suggests an interplay of transcriptional and translational control in mTOR response. Translation 1, 1–7 (2013). · DOI
  99. Larsson, O., Sonenberg, N. & Nadon, R. Anota: Analysis of differential translation in genome-wide studies. Bioinformatics 27, 1440–1441 (2011). · DOI
  100. Colman, H. et al. Genome-wide analysis of host mRNA translation during hepatitis C virus infection. J. Virol. 87, 6668–6677 (2013).This article shows that the analysis approach (Anota or translational-efficiency score) is critical for predicting whether differences in translation identified will correlate with changes in proteomes. Only Anota analysis corresponds to changes in protein amounts. · DOI
  101. Larsson, O. et al. Distinct perturbation of the translatome by the antidiabetic drug metformin. Proc. Natl. Acad. Sci. USA 109, 8977–8982 (2012). · DOI · Paper page
  102. Parker, M.W. et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124, 1622–1635 (2014). · DOI · Paper page
  103. Stumpf, C.R., Moreno, M.V., Olshen, A.B., Taylor, B.S. & Ruggero, D. The translational landscape of the mammalian cell cycle. Mol. Cell 52, 574–582 (2013). · DOI · Paper page
  104. Tebaldi, T., Dassi, E., Kostoska, G., Viero, G. & Quattrone, A. tRanslatome: an R/Bioconductor package to portray translational control. Bioinformatics 30, 289–291 (2014). · DOI
  105. Michel, A.M. et al. GWIPS-viz: development of a ribo-seq genome browser. Nucleic Acids Res. 42, D859–D864 (2014). · DOI · Paper page
  106. Schneider-Poetsch, T. et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol. 6, 209–217 (2010). · DOI · Paper page
  107. Lee, S. et al. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc. Natl. Acad. Sci. USA 109, E2424–E2432 (2012).
  108. Fresno, M., Jimenez, A. & Vazquez, D. Inhibition of translation in eukaryotic systems by harringtonine. Eur. J. Biochem. 72, 323–330 (1977). · DOI · Paper page
  109. Larsson, O. et al. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res. 67, 6814–6824 (2007). · DOI · Paper page
  110. Mamane, Y. et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2, e242 (2007). · DOI · Paper page
  111. Rajasekhar, V.K. et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12, 889–901 (2003). · DOI · Paper page
  112. Tominaga, Y., Tamguney, T., Kolesnichenko, M., Bilanges, B. & Stokoe, D. Translational deregulation in PDK-1−/− embryonic stem cells. Mol. Cell. Biol. 25, 8465–8475 (2005). · DOI
  113. Mikulits, W. et al. Isolation of translationally controlled mRNAs by differential screening. FASEB J. 14, 1641–1652 (2000). · doi:10.1096/fj.99-0852com
  114. Grolleau, A. et al. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 277, 22175–22184 (2002). · DOI · Paper page
  115. Ceppi, M. et al. Ribosomal protein mRNAs are translationally-regulated during human dendritic cells activation by LPS. Immunome Res. 5, 5 (2009). · DOI
  116. Kitamura, H. et al. Genome-wide identification and characterization of transcripts translationally regulated by bacterial lipopolysaccharide in macrophage-like J774.1 cells. Physiol. Genomics 33, 121–132 (2008). · DOI
  117. Ring, A.M. et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. 13, 1187–1195 (2012). · DOI · Paper page

Cited by

See all 248

Metadata

Authors
Piccirillo, C. A., Bjur, E., Topisirovic, I., Sonenberg, N., & Larsson, O.
Venue
Nature Immunology
Publisher
Springer Science and Business Media LLC
Published
2014-05-19
Volume
15
Issue
6
Pages
503-511
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
DOI
10.1038/ni.2891
OpenAlex
W2009776996
Cited by
248
References
16
FWCI
7.30
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translational control of immune responses: from transcripts to translatomes. https://app.cochat.ai/papers/10.1038/ni.2891
The paper
Piccirillo, C. A., Bjur, E., Topisirovic, I., Sonenberg, N., & Larsson, O. (2014). Translational control of immune responses: from transcripts to translatomes. Nature Immunology. https://doi.org/10.1038/ni.2891

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.